Yet he did speculate as Shawking pointed out in this quote from his blog released earlier today: "At the other end of the scale was Lexaria Bioscience (NASDAQ: LEXX) which gained +28.3% last week perhaps because of a story pointing out the links between LEXX and Jazz Pharma leading to a question of whether we could see a commercial agreement using DehydraTECH™ and Epidiolex®. " https://www.letstoke.biz/_files/ugd/449582_895d661d4a4e41b3b7efe884ea437d57.pdf
I thought perhaps your quote was a follow up to that.